Corn silk extract improves cholesterol metabolism in C57BL/6J mouse fed high-fat diets

키워드

참고문헌 (36)

1. Koska J, "Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals", Am J Clin Nutr, 87, pp.295~302 (2008)
2. Matsuzawa Y., "The metabolic syndrome and adipocytokines", FEBS Lett, 580, pp.2917~2921 (2006)
3. Doan DD, "Studies on the individual and combined diuretic effects of four Vietnamese traditional herbal remedies (Zea mays, Imperata cylindrica, Plantago major and Orthosiphon stamineus)", J Ethnopharmacol, 36, pp.225~231 (1992)
4. Hasanudin K, "Corn silk (Stigma maydis) in healthcare: a phytochemical and pharmacological review", Molecules, 17, pp.9697~9715 (2012)
5. Kan A, "In-vitro neuroprotective properties of the Maydis stigma extracts from four corn varieties", Int J Food Sci Nutr, 63, pp.1~4 (2012)
6. Velazquez DV, "Zea mays L. extracts modify glomerular function and potassium urinary excretion in conscious rats", Phytomedicine, 12, pp.363~369 (2005)
7. Zhao W, "Comparison of anti-diabetic effects of polysaccharides from corn silk on normal and hyperglycemia rats", Int J Biol Macromol, 50, pp.1133~1137 (2012)
8. Farsi DA, "Inhibition of non-enzymatic glycation by silk extracts from a Mexican land race and modern inbred lines of maize (Zea mays)", Phytother Res, 22, pp.108~112 (2008)
9. Suzuki R, "The favorable effect of style of Zea mays L. on streptozotocin induced diabetic nephropathy", Biol Pharm Bull, 28, pp.919~920 (2005)
10. Guo J, "The effects of corn silk on glycaemic metabolism", Nutr Metab (Lond), 6, pp.47~ (2009)
11. Maksimović Z, "Diuretic activity of Maydis stigma extract in rats", Pharmazie, 59, pp.967~971 (2004)
12. Bai H, "Protective effect of maize silks (Maydis stigma) ethanol extract on radiation-induced oxidative stress in mice", Plant Foods Hum Nutr, 65, pp.271~276 (2010)
13. Choi DJ, "Neuroprotective effects of corn silk maysin via inhibition of H2O2-induced apoptotic cell death in SK-N-MC cells", Life Sci, 109, pp.57~64 (2014)
14. Maksimović Z, "Polyphenol contents and antioxidant activity of Maydis stigma extracts", Bioresour Technol, 96, pp.873~877 (2005)
15. 김선림, "옥수수수염에 함유된 Flavonoids의 분리 및 동정", 한국작물학회지, 59(4), pp.435~444 (2014), 한국작물학회[DOI]
16. Waiss AC Jr, "Maysin, a flavone glycoside from corn silks with antibiotic activity toward corn earworm", J Econ Entomol, 72, pp.256~258 (1979)
17. Lee EA, "Genetic mechanisms underlying apimaysin and maysin synthesis and corn earworm antibiosis in maize (Zea mays L.)", Genetics, 149, pp.1997~2006 (1998)
18. Jeong HW, "A newly identified CG301269improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma", Diabetes, 60, pp.496~506 (2011)
19. 류동영, "3T3-L1 지방세포와 db", db 마우스에서 옥수수수염 물 추출물의 지방생성 억제 및 혈당 저하효과, 2011, pp.42(2), 201~208[DOI]
20. Schreyer SA, "C57BL", 6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis, 1998, pp.136, 17~24
21. Reeves PG., "Components of the AIN-93 diets as improvements in the AIN-76A diet", J Nutr, 127, pp.838S~841S (1997)
22. Folch J, "A simple method for the isolation and purification of total lipides from animal tissues", J Biol Chem, 226, pp.497~509 (1957)
23. 하애화, "The effect of fucoxanthin rich power on the lipid metabolism in rats with a high fat diet", Nutrition Research and Practice, 7(4), pp.287~293 (2013), 한국영양학회[DOI]
24. Dai W, "High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs", Nutr Metab (Lond), 12, pp.42~ (2015)
25. Kadowaki T, "Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome", J Clin Invest, 116, pp.1784~1792 (2006)
26. Li Y, "Adipose tissue regulates hepatic cholesterol metabolism via adiponectin", Life Sci, 118, pp.27~33 (2014)
27. Liu Q, "Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism", Proc Natl Acad Sci U S A, 109, pp.14568~14573 (2012)
28. Yamauchi T, "Globular adiponectin protected ob", ob mice from diabetes and ApoEdeficient mice from atherosclerosis, 2003, pp.278, 2461~2468
29. DeBose-Boyd RA., "Feedback regulation of cholesterol synthesis:sterol-accelerated ubiquitination and degradation of HMG CoA reductase", Cell Res, 18, pp.609~621 (2008)
30. Krause BR, "ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance", Arterioscler Thromb, 14, pp.598~604 (1994)
31. Davignon J, "HMG-CoA reductase inhibitors:a look back and a look ahead", Can J Cardiol, 8, pp.843~864 (1992)
32. Burnett JR, "Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs", Arterioscler Thromb Vasc Biol, 17, pp.2589~2600 (1997)
33. Burnett JR, "Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs", J Lipid Res, 40, pp.1317~1327 (1999)
34. Llaverías G, "Pharmacology of the ACAT inhibitor avasimibe (CI-1011)", Cardiovasc Drug Rev, 21, pp.33~50 (2003)
35. Evans MJ, "A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia", Am J Physiol Gastrointest Liver Physiol, 296, pp.G543~G552 (2009)
36. Mencarelli A, "FXR an emerging therapeutic target for the treatment of atherosclerosis", J Cell Mol Med, 14, pp.79~92 (2010)

관련 논문AI추천